Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$1.22B |
| 2 |
Johnson Controls International
JCI
|
+$1B |
| 3 |
Coupang
CPNG
|
+$883M |
| 4 |
Netflix
NFLX
|
+$810M |
| 5 |
Mastercard
MA
|
+$791M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4B |
| 2 |
Deere & Co
DE
|
+$1.19B |
| 3 |
Coca-Cola
KO
|
+$1.09B |
| 4 |
Comcast
CMCSA
|
+$1.04B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$1.02B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.97% |
| 2 | Technology | 17.27% |
| 3 | Financials | 14.72% |
| 4 | Industrials | 10.75% |
| 5 | Consumer Discretionary | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Agilysys
AGYS
$3.06B
| $23.5M | ﹤0.01% |
489,283
+203,493
| +71% | +$10.1M |
|
1027
XPeng
XPEV
$11.6B
| $23.3M | ﹤0.01% |
638,583
-80,668
| -11% | -$3.35M |
|
1028
Cytokinetics
CYTK
$10.4B
| $23.2M | ﹤0.01% |
996,277
-180,518
| -15% | -$3.85M |
|
1029
Warrior Met Coal
HCC
$4.86B
| $23.2M | ﹤0.01% |
1,352,611
-11,533
| -0.8% | -$243K |
|
1030
Porch Group
PRCH
$1.8B
| $23.2M | ﹤0.01% |
1,308,349
-965,315
| -42% | -$17.2M |
|
1031
Pediatrix Medical
MD
$2.2B
| $23.1M | ﹤0.01% |
+906,084
| New | +$23.2M |
|
1032
Edgewise Therapeutics
EWTX
$4.73B
| $23.1M | ﹤0.01% |
+742,412
| New | +$24.1M |
|
|
MNRL
1033
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $22.9M | ﹤0.01% |
1,561,595
-185,459
| -11% | -$2.69M |
|
1034
Armstrong World Industries
AWI
$7.84B
| $22.8M | ﹤0.01% |
253,438
+27,969
| +12% | +$2.37M |
|
1035
Perella Weinberg Partners
PWP
$1.3B
| $22.8M | ﹤0.01% |
2,037,403
+1,712,403
| +527% | +$19.2M |
|
1036
VEON
VEON
$3.95B
| $22.5M | ﹤0.01% |
507,675
-21,957
| -4% | -$962K |
|
1037
ProQR Therapeutics
PRQR
$265M
| $22.4M | ﹤0.01% |
3,394,246
-61,519
| -2% | -$314K |
|
1038
MVB Financial
MVBF
$389M
| $22.4M | ﹤0.01% |
662,002
+188,037
| +40% | +$5.27M |
|
1039
Colliers International
CIGI
$5.19B
| $22.3M | ﹤0.01% |
+227,384
| New | +$22.3M |
|
|
RAPT
1040
DELISTED
RAPT Therapeutics
RAPT
| $22.3M | ﹤0.01% |
125,497
-26,277
| -17% | -$4.33M |
|
1041
Liberty Media Series C
FWONK
$25.8B
| $22.2M | ﹤0.01% |
529,557
+2,136
| +0.4% | +$90.3K |
|
1042
Fabrinet
FN
$20.1B
| $22.2M | ﹤0.01% |
245,187
-58,608
| -19% | -$5.08M |
|
|
PDCE
1043
DELISTED
PDC Energy, Inc.
PDCE
| $22.1M | ﹤0.01% |
641,204
-135,980
| -17% | -$4.08M |
|
1044
AbbVie
ABBV
$435B
| $22M | ﹤0.01% |
203,659
-26,017
| -11% | -$2.78M |
|
1045
Astec Industries
ASTE
$1.02B
| $21.8M | ﹤0.01% |
288,722
+56,440
| +24% | +$3.83M |
|
1046
Mercury Systems
MRCY
$6.52B
| $21.7M | ﹤0.01% |
307,789
+4,966
| +2% | +$359K |
|
1047
Rhythm Pharmaceuticals
RYTM
$7.96B
| $21.6M | ﹤0.01% |
1,015,302
-1,085,925
| -52% | -$31.5M |
|
1048
Nucor
NUE
$62.1B
| $21.5M | ﹤0.01% |
267,431
-113,657
| -30% | -$6.89M |
|
1049
Q32 Bio
QTTB
$464M
| $21.4M | ﹤0.01% |
126,551
+7,496
| +6% | +$1.58M |
|
|
TBA
1050
DELISTED
Thoma Bravo Advantage
TBA
| $21.3M | ﹤0.01% |
+2,037,604
| New | +$23.6M |
|
Similar funds
Wellington Management Group's Q1 2021 Portfolio in Review
As of Q1 2021, Wellington Management Group held 2,278 positions worth $568B, up 4.6% from $543B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Wellington Management Group's Q1 2021 filing shows 381 new, 658 increased, 948 reduced and 197 closed positions. Its largest new stake was Coupang: 19,093,122 shares worth $901M. The largest sale was Apple, an estimated $4B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q1 2021 buy was Coupang: 19,093,122 shares worth $901M.
- Wellington Management Group added most to S&P Global in Q1 2021, an estimated $1.22B increase.
- Wellington Management Group's biggest Q1 2021 reduction was Apple, cutting an estimated $4B.
- Wellington Management Group fully exited BMC Stock Holdings, Inc in Q1 2021, selling an estimated $238M.
- Wellington Management Group's ten largest holdings make up 17% of its $568B portfolio in Q1 2021.
- Wellington Management Group opened 381 new positions and closed 197 in Q1 2021.
- Wellington Management Group's portfolio value rose 4.6% quarter-over-quarter to $568B.
Based on Wellington Management Group's 13F filing for Q1 2021, filed 17 May 2021.